Sun Pharmaceuticals Industries Ltd Reaches All-Time High, Rated as 'Buy' by MarketsMOJO

Mar 06 2024 01:25 PM IST
share
Share Via
Sun Pharmaceuticals Industries Ltd, a leading pharmaceutical company, has reached an all-time high in its stock price, showing strong performance and positive growth. Rated as a 'Buy' by MarketsMojo, the stock is trading close to its 52-week high and has outperformed the sector and benchmark index. With consistent positive performance and potential for growth, it is a promising investment opportunity in the largecap segment.

Sun Pharmaceuticals Industries Ltd, a leading pharmaceutical company in the largecap industry, has recently reached an all-time high in its stock price. On March 6, 2024, the company's stock price touched a record high, showing strong performance and positive growth.

According to MarketsMOJO, a leading stock market analysis platform, Sun Pharmaceuticals Industries Ltd's stock is currently rated as a 'Buy'. This is a positive indication for investors and reflects the company's strong potential for growth and profitability.

In terms of price performance, Sun Pharmaceuticals Industries Ltd is currently trading at a price that is only 0.09% away from its 52-week high of Rs 1587.85. This shows the company's consistent and impressive performance in the market. In fact, the stock has been gaining for the last 3 days and has risen by 2.28% in this period, outperforming the sector by 1.52%.

Moreover, Sun Pharmaceuticals Industries Ltd is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further highlights the company's strong performance and positive trend in the market.

In terms of overall performance, Sun Pharmaceuticals Industries Ltd has outperformed the Sensex, a benchmark index for the Indian stock market, by a significant margin. In the past year, the company's stock has shown a growth of 64.36%, while the Sensex has only grown by 22.05%. This shows the company's strong potential for growth and its ability to deliver positive returns for its investors.

Overall, Sun Pharmaceuticals Industries Ltd's recent all-time high in stock price and its consistent positive performance in the market make it a promising investment opportunity for investors in the pharma industry. With its strong track record and potential for growth, the company is definitely one to watch out for in the largecap segment.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News